Yonhap Infomax NewsFeb 11
Ligachem Bioscience founder Kim Yong-ju has launched The Iro Partners, a new VC firm with 3 billion won capital, to actively invest in and nurture South Korea's next wave of biotech startups, following his successful track record in drug development and technology licensing.
#YonhapInfomax #LigachemBioscience #KimYongJu #VentureCapital #BiotechStartups #TechnologyLicensing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104901
Ligachem Bio Founder Kim Yong-ju Launches VC Firm to Discover Promising Biotech Startups

Ligachem Bioscience founder Kim Yong-ju has launched The Iro Partners, a new VC firm with 3 billion won capital, to actively invest in and nurture South Korea's next wave of biotech startups, following his successful track record in drug development and technology licensing.

Yonhap Infomax
Oili YlivaaraDec 16

Technology licensing is a big thing for us at #VTTFinland and leap towards a larger scale manufacturing. Today #CanaryMedical has made an licensing agreement with VTT on our proprietary MEMS sensor technology for use in their implantable cardiovascular products

https://www.vttresearch.com/en/news-and-ideas/canary-medical-and-vtt-finalize-licensing-agreement-technology-further-enable

#MEMS #PMUT #PressureSensor #CardiovascularHealth #TechnologyLicensing #LicensingAgreement

Canary Medical and VTT finalize licensing agreement for technology to further enable development of Canary’s cardiovascular program | VTT

Canary Medical has licensed VTT’s proprietary sensor technology for use in its implantable cardiovascular products. Sensors will enable development and commercialization of new products designed to better manage chronic disease conditions. 

VTT